Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Express Scripts
Baxter
Cantor Fitzgerald
Covington
Chubb

Generated: March 19, 2019

DrugPatentWatch Database Preview

Desvenlafaxine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for desvenlafaxine and what is the scope of desvenlafaxine freedom to operate?

Desvenlafaxine is the generic ingredient in four branded drugs marketed by Alembic Pharms Ltd, Osmotica Pharm Corp, Sun Pharma Global, Teva Pharms Usa, Actavis Labs Fl, Casi Pharms Inc, Lupin Ltd, Mylan Pharms Inc, West-ward Pharms Int, Yichang Humanwell, Zydus Pharms Usa Inc, and Pf Prism Cv, and is included in fourteen NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for desvenlafaxine. Three suppliers are listed for this compound. There is one tentative approval for this compound.

Synonyms for desvenlafaxine
(RS)-1-[2-(dimethylamino)-1-(4-hydroxyphenyl)ethyl]cyclohexanol
(S)-Desmethyl Venlafaxine D6
1-[1-(4-hydroxyphenyl)-2-dimethylaminoethyl]cyclohexanol
1-[2-(dimethylamino)-1-(4-hydroxyphenyl)ethyl]cyclohexanol
1-[2-dimethylamino-1-(4-hydroxyphenyl)ethyl]cyclohexanol
4-(2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)phenol
4-[1-(1-hydroxycyclohexyl)-2-(dimethylamino)ethyl]phenol
4-[2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol
4-[2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol #
4-[2-(dimethylamino)-1-(1-oxidanylcyclohexyl)ethyl]phenol
4-[2-Dimethyamino-1-(1-hydroxycyclohexyl)ethyl]phenol
4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenol
413D628
4CH-007182
93413-62-8
A844583
AB0031560
AB01563022_01
AC1L2NUV
ACMC-20ek0k
AK-72949
AKOS015896311
AT-19352
AX8123273
BCP28517
BDBM86748
BR-72949
CAS_386750-22-7
CHEBI:83527
CHEMBL1118
CS-2818
CTK8E8385
d,l-O-Desmethylvenlafaxine
D07793
DB06700
Desvenlafaxine (INN)
Desvenlafaxine [INN:BAN]
Desvenlafaxine, 97%
desvenlafaxine(o-desnethylvenfaxine)
dl-o-desmethylvenlafaxin
DS-1282
DVS 233
EC 700-516-2
FT-0654519
GTPL7158
HMS3652K16
HSDB 7993
HY-B0602
I06-2078
J10126
KB-33580
Khedezla
Khedezla (TN)
KS-00000FZO
KYYIDSXMWOZKMP-UHFFFAOYSA-N
LS-178212
MLS006010042
MolPort-003-846-411
NCGC00345883-04
NSC_6918664
O-desmethyl venlafaxine
o-desmethyl venlafaxine-d10
O-desmethyl-venlafaxine
O-Desmethylvenlafaxine
O-DESMETHYLVENLAFAXINE (ODV)
O-Desmethylvenlafaxine 0.1 mg/ml in Methanol
O-Desmethylvenlafaxine solution, 1.0 mg/mL in methanol, certified reference material
O-Desmethylvenlafaxine solution, 100 mug/mL in methanol, ampule of 1 mL, certified reference material
O-Desmethylvenlafaxine, analytical standard
O-Desvenlafaxine
ODV
PDSP1_001804
PDSP2_001787
Phenol, 4-(2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)-
Phenol, 4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]-
S-2830
s4113
SB17444
SC-82264
SCHEMBL34864
SMR004701214
ST2410953
SW219514-2
TR-029259
WY 45,233
WY-45,233
Wy-45233
X4688
Tentative approvals for DESVENLAFAXINE
Applicant Application No. Strength Dosage Form
➤ Sign Up➤ Sign Up100MGTABLET, EXTENDED RELEASE;ORAL
➤ Sign Up➤ Sign Up50MGTABLET, EXTENDED RELEASE;ORAL

US Patents and Regulatory Information for desvenlafaxine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lupin Ltd DESVENLAFAXINE SUCCINATE desvenlafaxine succinate TABLET, EXTENDED RELEASE;ORAL 204172-001 Jun 29, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
West-ward Pharms Int DESVENLAFAXINE SUCCINATE desvenlafaxine succinate TABLET, EXTENDED RELEASE;ORAL 204082-001 Feb 16, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Actavis Labs Fl DESVENLAFAXINE SUCCINATE desvenlafaxine succinate TABLET, EXTENDED RELEASE;ORAL 204065-003 Jul 29, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pf Prism Cv PRISTIQ desvenlafaxine succinate TABLET, EXTENDED RELEASE;ORAL 021992-001 Feb 29, 2008 AB RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Alembic Pharms Ltd DESVENLAFAXINE SUCCINATE desvenlafaxine succinate TABLET, EXTENDED RELEASE;ORAL 204003-001 Jun 29, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Osmotica Pharm Corp KHEDEZLA desvenlafaxine TABLET, EXTENDED RELEASE;ORAL 204683-002 Jul 10, 2013 BC RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pf Prism Cv PRISTIQ desvenlafaxine succinate TABLET, EXTENDED RELEASE;ORAL 021992-002 Feb 29, 2008 AB RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Medtronic
Baxter
Chinese Patent Office
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.